Article
A Novel Therapeutic Approach using CXCR3 Blockade to Treat Immune Checkpoint Inhibitor-mediated Myocarditis
2024-02-02
Abstract excerpt
<h4>Background</h4> Immune checkpoint inhibitors (ICIs) are successful in treating many cancers but may cause immune-related adverse events. ICI-mediated myocarditis has a high fatality rate of up to 40%, with severe cardiovascular consequences. Targeted therapies for ICI myocarditis are currently lacking. <h4>Methods</h4> We used a genetic mouse model of PD-1 deletion ( MRL/Pdcd1-/- ) along with a novel drug-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c7ca221f-4683-5ede-a090-eda9271b65c4
- DOI
- 10.1101/2024.01.30.576279
